Vaporized CBD’s Motion-Detection Finding Did Not Match Its Driving Results
A vaporized CBD study detected a change in one visual measure without finding significant changes in simulated driving performance. The specific comparison matters: the significant pairwise motion-detection difference was between the two CBD conditions.
Vision and driving were assessed separately
Thirty participants completed placebo and two CBD conditions in a randomized crossover experiment. The tested CBD doses were approximately 16 and 32 mg. Investigators measured an overall driving-performance score and several visual functions.
The study also examined lane-position variability, reaction time, distance outside the lane and collisions. These are separate endpoints rather than interchangeable demonstrations of one overall safety state.
The visual result was selective
The overall motion-detection comparison was significant, and the reported pairwise contrast distinguished the lower- and higher-CBD conditions. Other visual measures did not show the same pattern. It would overstate the evidence to report that every visual function worsened versus placebo.
Overall simulated driving performance did not differ significantly between sessions. The secondary driving endpoints also did not show significant treatment differences, and correlations between visual measures and the overall driving score were not significant.
Neither a universal harm claim nor universal reassurance follows
A selected visual difference does not establish that CBD caused unsafe driving in this experiment. At the same time, null simulator results in a small sample cannot exclude every real-world effect or adverse response.
The findings concern acute vaporized CBD at these doses and the tested tasks. They should remain separate from oral CBD regimens, cannabis containing substantial THC, and longer-term exposure. A careful account names the visual endpoint and comparison while preserving the genuine null driving results.
Related: Why concentrations do not establish functional impairment.
Primary research
Visual function and vehicle driving performance under the effects of cannabidiol: A randomized cross‐over experiment. Addiction (Abingdon, England) (2025).
